About Tumentia Research

About company

Tumentia is a pharmaceutical company focused on the development of new therapies for cancer patients. The company was founded by graduates of the Concordia University in Montreal, Canada & the University of Wyoming in 2014. We develop novel therapies for cancer patients. Our research has resulted in five pre-clinical stage drugs that treat different types of cancers. Tumentia has been acquired by Excellence Health Inc. in October, 2017 & will now operate as a subsidiary.